MNOV Company Profile and Key Details

Q: Who are the executives of MNOV?

Mr. John O'Neil CPAControllerMr. Jason J. Kruger CPAChief Financial Officer & Principal Financial OfficerDr. Yuichi Iwaki M.D., Ph.D.Co-Founder, Pres, Chief Executive Officer & Executive DirectorDr. Kazuko Matsuda M.D., M.P.H., MPH, Ph.D.Chief Medical Officer & DirectorDr. David H. Crean M.B.A., Ph.D.Chief Bus. Officer

NASDAQ : MNOV

MediciNova

$1.41

At Close 4:00 PM

70.05

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

MediciNova, Inc. (MNOV) stock surged +2.13%, trading at $1.44 on NASDAQ, up from the previous close of $1.41. The stock opened at $1.38, fluctuating between $1.37 and $1.46 in the recent session.

Stock Snapshot

1.41

Prev. Close

70.77M

Market Cap

1.365

Day Low

-6

P/E Ratio

-0.24

EPS (TTM)

-0.15

Cash Flow per Share

1.38

Open

49.15M

Number of Shares

1.455

Day High

85.8%

Free Float in %

1.27

Book Value

39.61K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 03, 2026	1.40	1.42	1.38	1.41	71.38K
Mar 02, 2026	1.49	1.49	1.35	1.41	169.69K
Feb 27, 2026	1.55	1.55	1.45	1.45	55.1K
Feb 26, 2026	1.51	1.57	1.50	1.52	22.98K
Feb 25, 2026	1.42	1.52	1.42	1.48	119.82K
Feb 24, 2026	1.54	1.54	1.31	1.35	136.22K
Feb 23, 2026	1.47	1.54	1.47	1.49	31.66K
Feb 20, 2026	1.59	1.59	1.47	1.50	25.17K
Feb 19, 2026	1.56	1.59	1.55	1.55	40.69K
Feb 18, 2026	1.69	1.69	1.57	1.57	65.32K
Feb 17, 2026	1.56	1.63	1.55	1.60	58.39K
Feb 13, 2026	1.54	1.58	1.47	1.48	58.76K
Feb 12, 2026	1.61	1.62	1.56	1.56	42.13K
Feb 11, 2026	1.70	1.70	1.54	1.59	62.93K
Feb 10, 2026	1.80	1.80	1.63	1.63	35.84K
Feb 09, 2026	1.60	1.67	1.60	1.64	18.81K
Feb 06, 2026	1.65	1.68	1.60	1.60	54.15K
Feb 05, 2026	1.65	1.71	1.62	1.62	79.55K
Feb 04, 2026	1.64	1.66	1.63	1.63	47.71K
Feb 03, 2026	1.68	1.72	1.62	1.64	66.15K

Contact Details

La Jolla, CA 92037

United States

https://www.medicinova.com 858 373 1500

About Company

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.

Stock Peers

REGN

-24.1-3.05%

Regeneron Pharmaceuticals, Inc.$766.66 ARGX

-8.04-1.06%

argenx SE$748.72 UTHR

-15.17-2.95%

United Therapeutics Corporation$498.65 VRTX

-11.76-2.42%

Vertex Pharmaceuticals Incorporated$474.27 MDGL

-9.77-2.24%

Madrigal Pharmaceuticals, Inc.$425.85 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

-6.42-1.97%

Alnylam Pharmaceuticals, Inc.$318.65 PRAX

-12.37-3.74%

Praxis Precision Medicines, Inc.$318.22 KRYS

4.99+1.93%

Krystal Biotech, Inc.$263.80 ASND

-2.87-1.19%

Ascendis Pharma A/S$239.22

Frequently Asked Questions

What is the current MediciNova, Inc. (MNOV) stock price?

MediciNova, Inc. (NASDAQ: MNOV) stock price is $1.44 in the last trading session. During the trading session, MNOV stock reached the peak price of $1.46 while $1.37 was the lowest point it dropped to. The percentage change in MNOV stock occurred in the recent session was 2.13% while the dollar amount for the price change in MNOV stock was $0.03.

MNOV's industry and sector of operation?

The NASDAQ listed MNOV is part of Biotechnology industry that operates in the broader Healthcare sector. MediciNova, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MNOV?

Mr. John O'Neil CPA
Controller
Mr. Jason J. Kruger CPA
Chief Financial Officer & Principal Financial Officer
Dr. Yuichi Iwaki M.D., Ph.D.
Co-Founder, Pres, Chief Executive Officer & Executive Director
Dr. Kazuko Matsuda M.D., M.P.H., MPH, Ph.D.
Chief Medical Officer & Director
Dr. David H. Crean M.B.A., Ph.D.
Chief Bus. Officer

How MNOV did perform over past 52-week?

MNOV's closing price is 24.78% higher than its 52-week low of $1.13 where as its distance from 52-week high of $1.96 is -28.06%.

How many employees does MNOV have?

Number of MNOV employees currently stands at 13.

Link for MNOV official website?

Official Website of MNOV is: https://www.medicinova.com

How do I contact MNOV?

MNOV could be contacted at phone 858 373 1500 and can also be accessed through its website. MNOV operates from 4275 Executive Square, La Jolla, CA 92037, United States.

How many shares of MNOV are traded daily?

MNOV stock volume for the day was 39.61K shares. The average number of MNOV shares traded daily for last 3 months was 78.98K.

What is the market cap of MNOV currently?

The market value of MNOV currently stands at $70.77M with its latest stock price at $1.44 and 49.15M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	13
Beta	0.55
Sales or Revenue	$1.00M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	13
Beta	0.55
Sales or Revenue	$1.00M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

MNOV Company Profile and Key Details

MediciNova

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Key Takeaways

Valuation Metrics

Price Forecast & Outlook